Ticker brief
HUMA HUMACYTE INC
Consumer, Non-cyclical · Biotechnology
last close
$0.6501
1 day
-6.1%
14 days
+7.5%
mkt cap
$191.4M
signals 14d
16
authors 14d
7
crowd 14d
+1.9σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 131% mid · 47 pctile own 1y | IV/HV 1.33× (as of 2025-10-29) |
| Skew — 25Δ RR 30d | +0.212 86 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +1.62 elevated | 5-session Δ +0.96 (as of 2025-10-29) |
| OI alarm | quiet | last alarm 2025-10-08 (z=2.3) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-16 → 2026-08-24 · now +0.27 (−1 bearish … +1 bullish)
Who spoke7
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @PrismMarketView | C | · | 4 | +0.45 |
| @PolarizingLit | C | -0.24 | 3 | +0.25 |
| @BiopharmIQ | B | · | 3 | +0.33 |
| @Analytica_X | B | +1.03 | 2 | +0.35 |
| @PrismDM | A | -2.10 | 2 | +0.50 |
| @Tickeron | C | +0.16 | 1 | +0.25 |
| @AXInvestX | C | +0.51 | 1 | +0.80 |
Recent signals16of 16 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-24 | @PolarizingLit | +0.20 | Says a plan has been confirmed but the linked context is required to understand its significance. | -1.8% | tweet ↗ |
| 2026-08-24 | @BiopharmIQ | +0.20 | Dense biotech list reports trial, PDUFA, filing and approval developments with market moves. | -1.8% | tweet ↗ |
| 2026-08-24 | @PrismMarketView | +0.40 | Reports plans for a November supplemental BLA filing following FDA discussions. | -1.8% | tweet ↗ |
| 2026-08-21 | @BiopharmIQ | +0.40 | Summarizes the week's largest biotech movers and their associated catalysts. | +1.2% | tweet ↗ |
| 2026-08-20 | @Analytica_X | +0.40 | Reports CYPH rising 33% and HUMA rising 26% on accelerated speculative buying. | -4.6% | tweet ↗ |
| 2026-08-19 | @PrismMarketView | +0.45 | Summarizes index breadth, sector returns, and the day's largest individual-stock movers. | -11.5% | tweet ↗ |
| 2026-08-19 | @PolarizingLit | +0.20 | Lists defense-related names as potential beneficiaries of escalating Europe-Iran conflict | -11.5% | tweet ↗ |
| 2026-08-19 | @BiopharmIQ | +0.40 | Lists opening biotech movers and their associated trial, offering, facility and collaboration catalysts | -11.5% | tweet ↗ |
| 2026-08-19 | @AXInvestX | +0.80 | Calls HUMA the portfolio's best and most speculative holding and endorses buying when it is unwanted. | -11.5% | tweet ↗ |
| 2026-08-19 | @PrismDM | +0.40 | Midday-movers report provides exact gains, losses, prices and volumes. | -11.5% | tweet ↗ |
| 2026-08-19 | @PrismMarketView | +0.50 | Provides intraday prices, percentage moves, ranges, and volumes for multiple stocks. | -11.5% | tweet ↗ |
| 2026-08-19 | @PrismDM | +0.60 | Published Phase 3 results show ATEV significantly outperforming standard fistulas. | -11.5% | tweet ↗ |
| 2026-08-19 | @PrismMarketView | +0.45 | Reports peer-reviewed Phase 3 results showing superior six-month functional dialysis access. | -11.5% | tweet ↗ |
| 2026-08-18 | @PolarizingLit | +0.35 | Expresses praise associated with HUMA, though the linked context is unavailable. | +11.8% | tweet ↗ |
| 2026-08-17 | @Analytica_X | +0.30 | Reports share volume and relative-volume statistics for four unusually active stocks. | +16.0% | tweet ↗ |
| 2026-08-16 | @Tickeron | +0.25 | Reports HUMA volume rose for two days to 193% of its 65-day volume average. | +7.5% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.